首页> 外国专利> pharmaceutically acceptable compounds or salts thereof and pharmaceutical compositions and their uses of effective amounts and methods for treating, preventing, reversing, stopping or retarding the progression of selected disease or condition of fibrosis, cancer or respiratory disorders and modulating receptor activity in cells

pharmaceutically acceptable compounds or salts thereof and pharmaceutical compositions and their uses of effective amounts and methods for treating, preventing, reversing, stopping or retarding the progression of selected disease or condition of fibrosis, cancer or respiratory disorders and modulating receptor activity in cells

机译:药学上可接受的化合物或其盐和药物组合物及其有效量的用途以及用于治疗,预防,逆转,停止或延缓所选疾病或纤维化,癌症或呼吸系统疾病的病状并调节细胞中受体活性的方法

摘要

Compounds, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds to treat, prevent or diagnose diseases, disorders, or conditions associated with one or more of the lysophosphatidic acid receptors are provided.
机译:提供化合物,制备此类化合物的方法,包含此类化合物的药物组合物和药物,以及使用此类化合物治疗,预防或诊断与一种或多种溶血磷脂酸受体相关的疾病,病症或病状的方法。

著录项

  • 公开/公告号BR112014003499A2

    专利类型

  • 公开/公告日2017-06-13

    原文格式PDF

  • 申请/专利权人 INTERMUNE INC.;

    申请/专利号BR20141103499

  • 申请日2012-08-14

  • 分类号C07D207/34;A61K31/381;A61K31/415;A61K31/4155;A61K31/4192;A61K31/42;A61K31/421;A61K31/425;A61K31/426;A61K31/4427;A61P1/16;A61P9;A61P9/10;A61P11;A61P11/06;A61P19/04;A61P29;A61P35;C07D231/40;C07D249/06;C07D257/06;C07D261/14;C07D263/48;C07D275/03;C07D277/46;C07D307/66;C07D333/20;C07D401/04;C07D401/10;C07D405/12;C07D413/04;C07D413/10;C07D471/04;C07D491/04;C07D495/04;

  • 国家 BR

  • 入库时间 2022-08-21 13:40:39

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号